Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Anthony J. Apostoli"'
Publikováno v:
PPAR Research, Vol 2012 (2012)
ATP-dependent binding cassette (ABC) transporters are a family of transmembrane proteins that pump a variety of hydrophobic compounds across cellular and subcellular barriers and are implicated in human diseases such as cancer and atherosclerosis. In
Externí odkaz:
https://doaj.org/article/560acbde3a9241dea369e6cd9c192b59
Autor:
Joseph Paul Walton, Jalna Meens, Cheryl H. Arrowsmith, Julia Dmytryshyn, Laurie Ailles, Anthony J. Apostoli
Publikováno v:
Cancer Research. 80:1766-1766
Sporadic Renal Cell Carcinoma (RCC) is dominated by the clear cell subtype (ccRCC) and overwhelmingly associated with a biallelic inactivation of the von Hippel-Lindau (VHL) gene, leading to constitutive activation of the hypoxia response and deleter
Autor:
Laurie Ailles, Anthony J. Apostoli
Publikováno v:
Critical Reviews in Clinical Laboratory Sciences. 53:40-51
Human cancer is not a uniform disease but a plethora of disparate tumor types and subtypes. The differences that exist between individual tumors (intertumoral heterogeneity) present a significant roadblock to the eradication of cancer. It has also be
Autor:
Michael Di Lena, Graham Skelhorne-Gross, Sandip SenGupta, Rachel E. Rubino, Anthony J. Apostoli, Christopher J. Nicol, Nichole Peterson, Mark M. Schneider
Publikováno v:
International Journal of Cancer. Journal International du Cancer
Breast cancer is the leading cause of new cancer diagnoses among women. Using peroxisome proliferator-activated receptor (PPAR)γ((+/-)) mice, we showed normal expression of PPARγ was critical to stop 7,12-dimethylbenz[a]anthracene (DMBA)-induced br
Autor:
Andrew Evans, Laurie Ailles, Nazleen Lobo, Girish S. Kulkarni, Jason Moffat, Anthony J. Apostoli, Craig Gedye, Michael Robinette, Joshua Paterson, Antonio Finelli, Natalie Stickle, Kevin R. Brown, Neil Fleshner, Michael A.S. Jewett, Alexandre R. Zlotta, Robert J. Hamilton
Publikováno v:
BMC Cancer
Background Patients with clear cell renal cell carcinoma (ccRCC) have few therapeutic options, as ccRCC is unresponsive to chemotherapy and is highly resistant to radiation. Recently targeted therapies have extended progression-free survival, but res
Autor:
Elizabeth Lightbody, Kevin Ren, Anthony J. Apostoli, Christopher J. Nicol, Kathleen Mj O'Connell, Rachel R. Rubino, Sandip SenGupta, Hailey T. Newton
Publikováno v:
Cancer Research. 78:110-110
Breast tumors that overexpress human epidermal growth factor receptor 2 (HER2+) grow and spread faster than HER2-negative tumors, resulting in poor patient prognosis. Peroxisome proliferator-activated receptor (PPAR)γ is a nuclear transcription fact
Autor:
Anthony J. Apostoli, Dalia Barsyte-Lovejoy, Laurie Ailles, Nazleen Lobo, Cheryl Arrow Smith, Panagiotis Prinos
Publikováno v:
Cancer Research. 76:1240-1240
Clear cell renal cell carcinoma (ccRCC), the most common subtype of renal cell cancer, is highly resistant to traditional radiation and chemotherapy. Recently, targeted therapies have extended progression-free survival, but responses are variable and
Autor:
Christopher J. Nicol, Rachel E. Rubino, Alexis L Reid, Graham Skelhorne-Gross, Anthony J. Apostoli, Mark M. Schneider, Michael Di Lena, Sandip SenGupta, Frank J. Gonzalez, Nichole Peterson
Publikováno v:
Carcinogenesis. 33(7)
Peroxisome proliferator-activated receptor (PPAR)γ regulates the expression of genes essential for fat storage, primarily through its activity in adipocytes. It also has a role in carcinogenesis. PPARγ normally stops the in vivo progression of 7,12
Autor:
Anthony J. Apostoli
Publikováno v:
Health Science Inquiry. 2
Autor:
Mark M. Schneider, Nichole Peterson, Sandip SenGupta, Jennifer M Roche, Rachel E. Rubino, Christopher J. Nicol, Anthony J. Apostoli, Michael Di Lena
Publikováno v:
Molecular Cancer
Background Among women worldwide, breast cancer is the most commonly diagnosed cancer, and the second leading cause of cancer-related deaths. Improved understanding of breast tumourigenesis may facilitate the development of more effective therapies.